Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Mallinckrodt
AstraZeneca
Moodys
Johnson and Johnson
Dow
Boehringer Ingelheim

Last Updated: January 19, 2020

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: lixisenatide

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

lixisenatide

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Sanofi-aventis Us ADLYXIN lixisenatide SOLUTION;SUBCUTANEOUS 208471 NDA Sanofi-Aventis U.S. LLC 0024-5745-02 1 KIT in 1 CARTON (0024-5745-02) * 3 mL in 1 SYRINGE (0024-5741-01) * 3 mL in 1 SYRINGE (0024-5740-00)
Sanofi-aventis Us ADLYXIN lixisenatide SOLUTION;SUBCUTANEOUS 208471 NDA Sanofi-Aventis U.S. LLC 0024-5747-02 2 SYRINGE in 1 CARTON (0024-5747-02) > 3 mL in 1 SYRINGE
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
McKinsey
Boehringer Ingelheim
Colorcon
Merck
Dow